FDA Update: New Authority, Guidance and Pending Reforms Affecting the Life Sciences Industries

Life Sciences Webinar

February 18, 2026 | 12:00 PM ET

The FDA is off to a fast start this year with major policy announcements, a suite of new authorities given to it by Congress under the latest appropriations bill, new programs, and signs that it is getting ready to undertake a series of significant policy reforms related to drugs and medical devices.

Join AgencyIQ by POLITICO’s Life Sciences team on Wednesday, February 18 at 12:00 pm ET for a lively, informative, and actionable webinar exploring the FDA’s latest regulatory changes affecting the pharmaceuticals, biopharmaceutical, medical device, and diagnostics industries. We’ll explore the latest regulations, guidances, major policy developments and policy agendas. Plus, our experts will be on hand to answer your questions live.